Skip to main content
. 2019 Apr 24;22(3):390–397. doi: 10.1093/ntr/ntz090

Table 1.

Subject characteristics

All randomized subjects
n = 369
Placebo group
n = 188
Active group
n = 181
p a
Demographics
Age, years, mean (SD) 43.8 (14.5) 45.4 (15.0) 42.2 (13.8) .04
Gender, N (%) male 159 (43.1) 86 (45.7) 73 (40.3) .29
Race, N (%)
 White 187 (50.7) 93 (49.5) 94 (51.9) .32
 African-American 148 (40.1) 81 (43.1) 67 (37.0)
 Other 34 (9.2) 14 (7.5) 20 (11.1)
Hispanic, N (%) 20 (5.4) 9 (4.8) 11 (6.1) .58
Education, N (%) .86
 High school or less 88 (23.8) 45 (24.0) 43 (23.8)
 Some college 139 (37.7) 73 (38.8) 66 (36.4)
 Bachelor’s or above 142 (38.5) 70 (37.2) 72 (39.8)
Annual incomeb, $1,000s, mean (SD) 30.2 (26.8) 28.4 (26.2) 32.0 (27.4) .20
Smoking at enrollment
 Days smoking/week, mean (SD)c 3.6 (1.2) 3.6 (1.2) 3.6 (1.1) .95
 Number of cigarettes on smoking days, mean (SD)c 3.6 (2.5) 3.9 (2.9) 3.3 (2.0) .02
 Average cigarettes per day across all days (including days at 0), mean (SD)c 1.9 (1.5) 1.9 (1.5) 1.8 (1.5) .24
 Smoke mentholdN (%) 239 (65.5) 124 (66.7) 115 (64.3) .63
 Years smoked, mean (SD) 21.2 (14.2) 22.1 (15.2) 20.3 (13.1) .23
 Past daily smoker, N (%) 202 (54.7) 104 (55.3) 98 (54.1) .82
Fagerstrom Test for Nicotine Dependence= 0, N (%) 230 (62.7) 119 (63.6) 111 (61.7) .70

Abbreviations: SD = standard deviation; N = number.

aComparison between active and placebo groups. Chi-square test for categorical variables, t-test for continuous variables.

bComputed from categorical reports, using midpoints from 12 categories, from <$5,000 to >$80,000.

cBased on time-line follow-back (TLFB) reporting in the 28 days prior to study enrollment.

dMenthol smoking was reported by 94% of African-American participants; among other ethnicities, this was 43%.